US 11,701,360 B2
Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition
Kang-Yell Choi, Seoul (KR); Mi-Yeon Kim, Seoul (KR); and Sungho Han, Seoul (KR)
Assigned to GENUV Inc., Seoul (KR)
Filed by GENUV Inc., Seoul (KR)
Filed on Aug. 31, 2021, as Appl. No. 17/463,219.
Application 17/463,219 is a division of application No. 16/545,438, filed on Aug. 20, 2019.
Application 16/545,438 is a division of application No. 15/897,138, filed on Feb. 14, 2018, granted, now 10,485,802, issued on Nov. 26, 2019.
Application 15/897,138 is a continuation of application No. PCT/KR2017/013444, filed on Nov. 23, 2017.
Prior Publication US 2021/0401844 A1, Dec. 30, 2021
Int. Cl. A61K 31/519 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01)
CPC A61K 31/519 (2013.01) [A61P 25/16 (2018.01); A61P 25/28 (2018.01)] 12 Claims
OG exemplary drawing
 
1. A method of treating a neurodegenerative disease, comprising the step of: administering trametinib to a patient diagnosed with the neurodegenerative disease,
wherein the neurodegenerative disease is selected from the group consisting of: dementia, vascular dementia, senile dementia, frontotemporal dementia, Lewy body dementia, Parkinson's disease, multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, Huntington's disease, and cerebellar ataxia.